CCDC86 and diffuse large B-cell lymphoma: In this context, we have previously shown that CYCLON, a novel nuclear phosphoprotein was acting as an autonomous tumor growth driver and anti-CD20 treatment resistance factor in DLBCL in vitro and in a xenograft mouse model [10].